脑白质高信号与缺血性卒中长期结局的系统综述与荟萃分析
该系统综述与荟萃分析纳入104项队列研究共71,298例缺血性卒中患者,评估基线MRI或CT所见的脑白质高信号(WMH)与长期痴呆、功能损害、卒中复发和死亡风险的关系。结果显示中重度WMH与痴呆、认知损害、功能损害、任何卒中复发、复发性缺血性卒中、全因死亡和心血管死亡风险增加相关,且呈剂量反应模式,MRI与CT定义的结果一致。
要点
- 中重度WMH与缺血性卒中后痴呆风险增加相关(RR 2.17,95%CI 1.72-2.73)。
- WMH严重程度与功能损害、卒中复发和死亡风险呈剂量反应关系。
- WMH可用于临床预后判断和未来临床试验规划。
核心结论
- 基线WMH的存在和严重程度与缺血性卒中后痴呆、功能损害、卒中复发和死亡风险显著增加相关。
研究设计与样本
- 遵循MOOSE和PRISMA指南(PROSPERO注册号CRD42018092857),系统检索Medline和Scopus,纳入104项队列研究共71,298例缺血性卒中患者,评估基线MRI或CT所见的WMH与卒中后3个月或更晚的痴呆、功能损害、卒中复发和死亡的关系,采用随机效应模型合并相对风险(RR),用Newcastle-Ottawa量表评价研究质量。
主要发现
- 中重度WMH与痴呆风险增加相关(RR 2.17,95%CI 1.72-2.73)。
- 中重度WMH与认知损害风险增加相关(RR 2.29,95%CI 1.48-3.54)。
- 中重度WMH与功能损害风险增加相关(RR 2.21,95%CI 1.83-2.67)。
- 中重度WMH与任何卒中复发风险增加相关(RR 1.65,95%CI 1.36-2.01),与复发性缺血性卒中风险增加相关(RR 1.90,95%CI 1.26-2.88)。
- 中重度WMH与全因死亡风险增加相关(RR 1.72,95%CI 1.47-2.01),与心血管死亡风险增加相关(RR 2.02,95%CI 1.44-2.83)。
关键数值与推荐
- WMH严重程度与结局关联呈剂量反应模式,MRI和CT定义的WMH结果一致。
- 调整年龄、卒中严重程度和心血管危险因素、高质量研究分析及发表偏倚调整后结果稳定。
临床怎么用
- 基线WMH可用于缺血性卒中患者的临床预后判断,辅助识别痴呆、功能损害、卒中复发和死亡高风险患者。
- WMH信息可能有助于未来临床试验的规划和风险分层。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate the relationship between baseline white matter hyperintensities (WMH) in patients with ischemic stroke and long-term risk of dementia, functional impairment, recurrent stroke, and mortality. METHODS: Following the Meta-analysis of Observational Studies in Epidemiology and Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines (PROSPERO protocol: CRD42018092857), we systematically searched Medline and Scopus for cohort studies of ischemic stroke patients examining whether MRI- or CT-assessed WMH at baseline are associated with dementia, functional impairment, recurrent stroke, and mortality at 3 months or later poststroke. We extracted data and evaluated study quality with the Newcastle-Ottawa scale. We pooled relative risks (RR) for the presence and severity of WMH using random-effects models. RESULTS: We included 104 studies with 71,298 ischemic stroke patients. Moderate/severe WMH at baseline were associated with increased risk of dementia (RR 2.17, 95% confidence interval [CI] 1.72-2.73), cognitive impairment (RR 2.29, 95% CI 1.48-3.54), functional impairment (RR 2.21, 95% CI 1.83-2.67), any recurrent stroke (RR 1.65, 95% CI 1.36-2.01), recurrent ischemic stroke (RR 1.90, 95% CI 1.26-2.88), all-cause mortality (RR 1.72, 95% CI 1.47-2.01), and cardiovascular mortality (RR 2.02, 95% CI 1.44-2.83). The associations followed dose-response patterns for WMH severity and were consistent for both MRI- and CT-defined WMH. The results remained stable in sensitivity analyses adjusting for age, stroke severity, and cardiovascular risk factors, in analyses of studies scoring high in quality, and in analyses adjusted for publication bias. CONCLUSIONS: Presence and severity of WMH are associated with substantially increased risk of dementia, functional impairment, stroke recurrence, and mortality after ischemic stroke. WMH may aid clinical prognostication and the planning of future clinical trials.
引用
- Georgakis MK, Duering M, Wardlaw JM, et al. WMH and long-term outcomes in ischemic stroke: A systematic review and meta-analysis. Neurology. 2019. PMID: 30770431. doi:10.1212/WNL.0000000000007142
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。